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12 months). RESULTS: Patients mean  SD age was
55  15 years and 77% were female. Mean  SD MAF
score was 23.3  12.3 with a normal range of 1(no fa-
tigue)–50(fatigue). Mean FACIT-F score was 33.2  9.3
with a normal range of 52 (no fatigue)–0 (fatigue). The
aggregate scores for each instrument were highly corre-
lated with a Pearson’s coefficient of 0.81 (p  0.001).
CONCLUSION: Based on this analysis, it appears that
the FACIT-F has validity for use in the early RA popula-
tion. However, as follow-up assessments are completed, a
more detailed analysis may reveal additional psychomet-
ric properties of the instrument in the early RA popula-
tion and with disease progression.
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OBJECTIVES: This review identifies instruments for
measuring functional status among workers with mild-
to-moderate disorders of the upper extremity. Functional
status measures correlate pain and discomfort to perfor-
mance, with direct, practical relevance to employers and
workers. While many functional status measures exist for
patients with severe or degenerative illness, few measures
were designed for relatively healthy active workers. In
fact, the impact of mild-to-moderate disorders on the
workforce is largely unknown. The recently released
OSHA Ergonomics Program Standard has given this issue
a new sense of urgency. The intent is to give investigators
a tool for choosing appropriate functional status mea-
sures in a specific research or clinical context. METH-
ODS: To identify self-reported functional status instru-
ments for upper extremity disorders among workers, a
Medline literature search was conducted for English-lan-
guage publications between the years 1966 and 2000.
Keywords included: carpal tunnel syndrome, functional
status, health surveys, musculoskeletal, occupational
health, outcome measures, questionnaire, neck, upper ex-
tremity, and worker. In selecting functional status instru-
ments for review, three criteria were used: 1) Relevance
to neck and upper extremity conditions (indicated by
question content); 2) Assessment among workers; and 3)
Relevance to mild-to-moderate disorders (indicated by
level of severity). Parameters of interest were validity,
reliability, and responsiveness to change. RESULTS:
Among 13 functional status instruments reviewed, six
measures were tested among workers, including three
measures relevant for mild-to-moderate disorders: the
Nordic Musculoskeletal Questionnaire, Upper Extremity
Questionnaire, and Neck and Upper Limb Instrument.
CONCLUSIONS: The identification of three functional
status measures should encourage their use in studies, to
improve communication among investigators. Further re-
search is needed to address neglected aspects of measure-
ment—specifically, for mild-to-moderate upper extremity
disorders among workers—and to standardize valid and
reliable instruments.
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OBJECTIVE: The aim of this study was to determine the
cost-effectiveness of Acetylcysteïne and DMSO in the
treatment of patients with reflex sympathic dystrophy
(RSD). METHODS: The study was a prospective, dou-
ble-dummy, double blind, controlled trial. Patients were
followed for one year. The primary outcome measure
was the Impairment-level Sum Score (ISS). Cost data
were prospectively collected using cost-diaries. Utilities
were determined using the EuroQol. Both cost-effective-
ness and cost-utility analyses were performed. Differ-
ences in mean direct, indirect and total costs between
groups were estimated with corresponding 95% Confi-
dence Intervals (CI). Also cost-effectiveness and cost-util-
ity ratios with corresponding 95% CI were calculated us-
ing bootstrapping techniques. RESULTS: There was a
statistically significant difference in effect (ISS). DMSO
generated more reduction than Acetylcysteïne (diff: 1.82
CI:4.90;1.27). This significant difference appeared
also in the subgroup of patients with warm RSD. The to-
tal costs were statistically significant lower in the DMSO
compared to the Acetylcysteïne group (diff: 2866 CI:
666;5179). This significant difference was also found in
the subgroup of patients with warm RSD. The cost-effec-
tiveness and cost-utility ratios showed that DMSO is
dominant over Acetylcysteïne. CONCLUSION: In gen-
eral, DMSO is the preferred method of treatment for pa-
tients with RSD. There are some indications that Acetyl-
cisteïne may be more cost-effective for cold RSD, but this
was found in a small subgroup only and should be con-
firmed in a larger trial.
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OBJECTIVES: This paper presents the results of an eco-
nomic evaluation in conjunction with a randomized con-
trolled trial to evaluate the cost-effectiveness of manual
therapy, physical therapy and GP care for patients with
